Unlocking the future of pharmaceutical innovation a niche yet rapidly expanding sector is reshaping how cutting-edge therapies reach patients worldwide. The surge in demand for peptide and oligonucleotide-based drugs is driving a parallel boom in specialized contract development and manufacturing organizations that provide tailored solutions to biopharma companies. These partners play a pivotal...